IGI Laboratories, Inc. - Company Profile and Financial Analysis

  • Category : Company Profiles
  • Published On : June   2015
  • Pages : 28
please select format
 
Summary
Canadeans IGI Laboratories, Inc. - Company Profile and Financial Analysis contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, financial ratios, key competitors, financial analysis, recent developments, key employees as well as company locations and subsidiaries.

Key Findings
This report is a crucial resource for industry executives and anyone looking to access key information about IGI Laboratories, Inc.

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Canadean strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Synopsis
- Identifies crucial company information about IGI Laboratories, Inc. along with major products and services for business intelligence requirements.

- Provides key ratios on companys financial performance.

- Identifies key employees to assist with key business decisions.

- Provides annual and interim financial ratios.

Reasons To Buy
- Enhance your understanding of IGI Laboratories, Inc.

- Increase business/sales activities by understanding customers businesses better.

- Recognize potential partnerships and suppliers.

- Qualify prospective partners, affiliates or suppliers.

- Acquire up-to-date company information and an understanding of the companys financial health.

Key Highlights
IGI Laboratories, Inc. (IGI Laboratories) is a manufacturer and supplier of pharmaceutical products. The company offers topical prescription drugs. Its products include econazole cream, fluocinolone acetonide ointment, fluocinolone acetonide cream, fluocinolone acetonide topical solution and lidocaine. IGI Laboratories markets its products under the brands of IGI and Novasome. The company offers development, formulation and manufacturing services. It serves pharmaceutical, cosmetic and drug manufacturing industries. The company sells its products through a network of pharmacies located across the US. IGI Laboratories is headquartered in Buena, New Jersey, the US.

Table Of Contents
1 IGI Laboratories, Inc.
2 IGI Laboratories, Inc. - Key Employees
3 IGI Laboratories, Inc. - Major Products and Services
4 IGI Laboratories, Inc. - Key Events
5 IGI Laboratories, Inc. - Locations and Subsidiaries
5.1 IGI Laboratories, Inc. - Head Office
6 IGI Laboratories, Inc. - Business Analysis
6.1 IGI Laboratories, Inc. - Company Overview
7 IGI Laboratories, Inc. - Company Financial Analysis
7.1 IGI Laboratories, Inc. - Five Year Snapshot: Overview of Financial and Operational Performance Indicators
8 IGI Laboratories, Inc. - Interim ratios
8.1.1 IGI Laboratories, Inc. - Financial ratios: Capital Market Ratios
8.2 IGI Laboratories, Inc. - Financial Performance and Ratio Charts
8.2.1 IGI Laboratories, Inc. - Revenue and Operating margin
8.2.2 IGI Laboratories, Inc. - Asset and Liabilities
8.2.3 IGI Laboratories, Inc. - Operational Efficiency
8.2.4 IGI Laboratories, Inc. - Solvency
8.2.5 IGI Laboratories, Inc. - Valuation
8.3 IGI Laboratories, Inc. - Key Competitors
9 IGI Laboratories, Inc. - Recent Developments
10 Appendix
10.1 Methodology
10.2 IGI Laboratories, Inc. - Ratio Definitions
10.3 Disclaimer
List Of Tables
Table 1: IGI Laboratories, Inc. - Key Employees
Table 2: IGI Laboratories, Inc. - Major Products and Services
Table 3: IGI Laboratories, Inc. - Key Events
Table 4: IGI Laboratories, Inc. - Annual ratios
Table 5: IGI Laboratories, Inc. - Interim ratios
Table 6: IGI Laboratories, Inc. - Capital Market Ratios
List Of Figures
Figure 1: IGI Laboratories, Inc. - Revenue and Operating Profit
Figure 2: IGI Laboratories, Inc. - Financial Position
Figure 3: IGI Laboratories, Inc. - Operational Efficiency
Figure 4: IGI Laboratories, Inc. - Solvency
Figure 5: IGI Laboratories, Inc. - Valuation
close

category